Efficacy of Trametinib in Neurofibromatosis Type 1-Associated Gastrointestinal Stromal Tumors: A Case Report.

Published in: JCO precision oncology (2024)

Trametinib, an MEK inhibitor, may offer a new therapeutic option for patients with NF1-related GIST.

Keyphrases